NGD 91-3: Began Phase II trial

A previous Phase I trial suggested that single doses of predecessor

Read the full 118 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE